Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-29 5:01 pm Sale |
2024-01-25 | 13D | Longboard Pharmaceuticals, Inc. LBPH |
PFIZER INC PFE |
0 0.000% |
-3,978,540 (Position Closed) |
Filing History |
| 2024-01-29 1:04 pm Purchase |
2023-12-31 | 13G | Pfizer Inc. PFE |
STATE STREET CORP STT |
287,875,814 5.100% |
2,932,117 (+1.03%) |
Filing History |
| 2024-01-26 11:49 am Sale |
2023-12-31 | 13G | Pfizer Inc. PFE |
BLACKROCK INC BLK |
434,748,255 7.700% |
-8,120,506 (-1.83%) |
Filing History |
| 2024-01-19 4:20 pm Unchanged |
2024-01-16 | 13D | Haleon plc HLN |
PFIZER INC PFE |
2,955,063,626 32.000% |
0 (Unchanged) |
Filing History |
| 2024-01-10 4:12 pm Unchanged |
2024-01-08 | 13D | Longboard Pharmaceuticals, Inc. LBPH |
PFIZER INC PFE |
3,978,540 11.260% |
0 (Unchanged) |
Filing History |
| 2023-10-27 4:01 pm Purchase |
2023-10-19 | 13G | Tourmaline Bio, Inc. TRML |
PFIZER INC PFE |
1,272,214 6.260% |
1,272,214 (New Position) |
Filing History |
| 2023-10-25 5:29 pm Unchanged |
2023-08-02 | 13D | Allogene Therapeutics, Inc. ALLO |
PFIZER INC PFE |
22,032,040 13.140% |
0 (Unchanged) |
Filing History |
| 2023-10-18 4:27 pm Unchanged |
2023-10-12 | 13D | Cerevel Therapeutics Holdings, Inc. CERE |
PFIZER INC PFE |
27,349,211 15.400% |
0 (Unchanged) |
Filing History |
| 2023-10-10 4:11 pm Unchanged |
2023-10-05 | 13D | Haleon plc HLN |
PFIZER INC PFE |
2,955,063,626 32.000% |
0 (Unchanged) |
Filing History |
| 2023-09-11 4:08 pm Unchanged |
2023-09-11 | 13D | Haleon plc HLN |
PFIZER INC PFE |
2,955,063,626 32.000% |
0 (Unchanged) |
Filing History |
| 2023-07-10 09:10 am Purchase |
2023-06-30 | 13G | Caribou Biosciences, Inc. CRBU |
PFIZER INC PFE |
4,690,431 7.100% |
4,690,431 (New Position) |
Filing History |
| 2023-05-15 4:45 pm Unchanged |
2023-05-11 | 13D | Haleon plc HLN |
PFIZER INC PFE |
2,955,063,626 32.000% |
0 (Unchanged) |
Filing History |
| 2023-03-30 5:02 pm Purchase |
2023-03-20 | 13G | Zura Bio Limited ZURA |
PFIZER INC PFE |
2,970,022 10.780% |
2,970,022 (New Position) |
Filing History |
| 2023-03-27 4:27 pm Unchanged |
2023-02-07 | 13D | Longboard Pharmaceuticals, Inc. LBPH |
PFIZER INC PFE |
3,978,540 17.300% |
0 (Unchanged) |
Filing History |
| 2023-03-23 4:20 pm Purchase |
2023-03-17 | 13G | Pyxis Oncology, Inc. PYXS |
PFIZER INC PFE |
7,032,770 19.020% |
1,811,594 (+34.70%) |
Filing History |
| 2023-02-13 5:14 pm Purchase |
2022-12-31 | 13G | Pyxis Oncology, Inc. PYXS |
PFIZER INC PFE |
5,221,176 14.880% |
2,229,654 (+74.53%) |
Filing History |
| 2023-02-13 5:06 pm Purchase |
2022-12-31 | 13G | AN2 Therapeutics, Inc. ANTX |
PFIZER INC PFE |
1,362,499 7.020% |
1,362,499 (New Position) |
Filing History |
| 2023-02-09 11:30 am Purchase |
2022-12-30 | 13G | Pfizer Inc. PFE |
The Vanguard Group | 501,636,220 8.940% |
36,361,295 (+7.82%) |
Filing History |
| 2023-02-07 1:11 pm Sale |
2022-12-31 | 13G | Pfizer Inc. PFE |
STATE STREET CORP STT |
284,943,697 5.080% |
-827,894 (-0.29%) |
Filing History |
| 2023-02-03 4:27 pm Purchase |
2022-12-31 | 13G | Pfizer Inc. PFE |
BLACKROCK INC BLK |
442,868,761 7.900% |
32,883,116 (+8.02%) |
Filing History |